Nasan Medical Systems Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 04-10-2024
- Paid Up Capital ₹ 3.11 M
as on 04-10-2024
- Company Age 24 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 33.86%
(FY 2022)
- Profit -9.66%
(FY 2022)
- Ebitda -16.03%
(FY 2022)
- Net Worth -13.89%
(FY 2022)
- Total Assets -0.73%
(FY 2022)
About Nasan Medical Systems
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 3.11 M, as per Ministry of Corporate Affairs (MCA) records.
Yashwant Samant, Nachiket Samant, and Veena Markandeya serve as directors at the Company.
- CIN/LLPIN
U33112PN2000PLC018531
- Company No.
018531
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Mar 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nasan Medical Systems?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veena Markandeya  | Director | 25-Jul-2022 | Current |
| Yashwant Samant | Director | 08-Mar-2000 | Current |
| Nachiket Samant | Director | 14-May-2018 | Current |
Financial Performance and Corporate Structure Insights of Nasan Medical Systems.
Nasan Medical Systems Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 33.86% increase. The company also saw a slight decrease in profitability, with a 9.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nasan Medical Systems?
In 2018, Nasan Medical Systems had a promoter holding of 91.12% and a public holding of 8.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nasan Medical Electronics Pvt LtdActive 33 years 1 monthYashwant Samant, Nachiket Samant and 1 more are mutual person
- Healthcare Clinicset Private LimitedActive 8 years 10 months
Yashwant Samant, Nachiket Samant and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nasan Medical Systems?
Unlock and access historical data on people associated with Nasan Medical Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nasan Medical Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nasan Medical Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
